Drug
Ak157d1 For
Ak157d1 For: highest development phase Phase 1, developed by Akeso. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Akeso
Trials
| Drug | Phase | Indication |
|---|---|---|
| AK157D1 for injection NCT07847281 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Ak157d1 For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.